ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,768, issued on Aug. 12, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).
"Isoxazole carboxylic acids as LPA antagonists" was invented by Peter Tai Wah Cheng (Princeton, N.J.), Hao Zhang (Belle Mead, N.J.), Robert F. Kaltenbach III (Holland, Pa.), Jun Li (Pittsburgh), Steven J. Walker (Portage, Mich.) and Yan Shi (Flourtown, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors."
The patent was filed o...